Ethers of 7-desmethlrapamycin
US6440991B1 · kind B1 · utility
63Cited by
56References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 2001 |
| Grant date | Aug 27, 2002 |
| Priority date | — |
| Expiry date | Sep 19, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides ethers of 7-desmethylrapamycin which are useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.